Please follow the instructions below, and send a complete pdf file  document to Pilot and Feasiblity Coordinator Jacqueline Ismen at JIsmen@mednet.ucla.edu and Catia Sternini, M.D., Pilot and Feasibility Program Director at csternin@ucla.edu by the deadline December 15 ,2018. 

Please include the following as one pdf attachment:

The application consists of the CURE Pilot and Feasibility Cover page, form pages, specific aims, research strategy, and progress report (if application is a second year renewal). The specific aims, research strategy and/or progress report should be maximum 5 pages including figures. References should be no more than 2 page max. Please see details below.

Application Details:

1) CURE Pilot and Feasibility Cover Page (please click on "cover page" to access the form)

2) Forms and Instructions, please visit this  NIH link for forms and instructions. Please include Face Page and Form Pages 1-5 and the resources page.  Please, specify that the budget should be only for one year. 
Face Page 1 - cover page. Please follow instructions. OCGA signature and contact information are not required as this is an internally funded grant.

Budget: Awards range up to $40,000/year, please follow the PHS Budget Forms - direct cost only. Funds may be used for Salary, Supplies and  travel. Travel expenses are allowed, if related to the Pilot and Feasibility project. Please include the budget justification in the NIH format, Page I-33 of the NIH Instructions for using grant applications.

3) NIH biosketch- REVISED

4) the 5 pages length refers to narrative section including specific aims, research strategy, and progress report (if application is a second year renewal) and does not include the form pages.

5) references 2 pages max

6) Category 1 applications:  The required letter from the mentor should clearly state the source of funds (e.g. title and dates of grants or other funds) to support the full applicant's salary and provide the needed resources for the applicant to perform the proposed research. The letter should also confirm that the applicant's project differs from the mentor own research program and outline the mentor’s role in overseeing the research and guiding the applicant’s career development.

Please submit one combined PDF file and email to Catia Sternini, MD at csternin@g.ucla.edu and cc: Jacqueline Ismen at JIsmen@mednet.ucla.edu

STOP HERE. 

Please note, if the application is selected for funding, both CTSI and CURE will request additional materials:  NIH mandated Human Subjects Protection Section, IRB approvals, waivers, exemptions and the online Human Subjects education certification  will be requested. These items are not required for the initial application but will be requested if the application is selected for funding.  Proposals involving more than minimal risk to human subjects will require pre-approval by the NIH. Proposals involving NIH defined Clinical Trials will require pre-approval by the NIH.  Please note, funding will not be released until the requested information is received and appropriate IRB approvals are in place. CTSI will request NIH mandated items in a separate email.

a. Basic outline for Human Subjects Protections Requirement

b.Supplemental Grant Application Instructions

c. NIH website Human Subjects Protection Guidance

d. Data Safety Monitoring Plan (DSMB) guidelines

e. Planned Enrollment Forms

Please note that an ERA Commons ID will be required for CURE/CTSI Pilot and Feasibility Awardees:

To request new eRA Commons accounts or modifications to existing accounts, please send e-mail to OCGA eRA Coordinator, Cindy Gilbert, with the following information:

  • Full Name
  • E-mail address
  • Requested Role(s) - e.g. Principal Investigator, CURE/CTSI Pilot and Feasibility Application

IRB and ARC Approvals:

If awarded, funding will not be released unless appropriate IRB and ARC approvals have been submitted. Please note: UCLA IRB approval will be required if the applications include a human studies component. If studies are conducted at the West Los Angeles  VA, UCLA IRB approval for Human Studies involved in research must be submitted to the program coordinator prior to the release of funds.  UCLA IRB and ARC approval notices must cite the CURE: DDRC and CTSI funding sources.

Agency Name: NIH/NIDDK
PI of Contract/Grant: J.Enrique Rozengurt, DVM, PhD
Contract/Grant Title: CURE:Digestive Diseases Research Center (intramural award to [insert name] for "[insert PFS title])
Contract/Grant No: NIH DK41301

Agency Name: NIH/National Center for Advancing Translational Sciences
PI of Contract/Grant: Steven Dubinett, MD
Contract/Grant Title: UCLA Clinical and Translational Science Institute (intramural award to [insert name] for "[insert PFS title])
Contract/Grant No: UL1TR001881

For questions, please contact CURE PFS Coordinator, Jacqueline Ismen at JIsmen@mednet.ucla.edu or Catia Sternini, M.D., Program Director, at csternin@ucla.edu